Who owns Matinas Biopharma Holdings, In?

Tip: Access positions for across all investors

Analyze quarterly positions in Matinas Biopharma Holdings, In with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Matinas Biopharma Holdings, In stock

Who bought or sold Matinas Biopharma Holdings, In this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 9.3M $2.0M 6% Dec 2023
 View chart
Sargent Investment Group 3.8M $826k -3% Dec 2023
 View chart
BlackRock 2.5M $329k 0% Sep 2023
 View chart
Geode Capital Management 2.0M $255k 0% Sep 2023
 View chart
Arkadios Wealth Advisors 1.6M $351k 16% Dec 2023
 View chart
Neville Rodie & Shaw 1.2M $250k 0% Dec 2023
 View chart
JTC Employer Solutions Trustee 775k $176k 0% Dec 2023
 View chart
State Street Corporation 713k $93k 0% Sep 2023
 View chart
LPL Financial 618k $80k 0% Sep 2023
 View chart
Main Street Financial Solutions 401k $87k 0% Dec 2023
 View chart
Staley Capital Advisers 400k $87k 0% Dec 2023
 View chart
Northern Trust 362k $47k 0% Sep 2023
 View chart
Private Advisor 337k $73k 31% Dec 2023
 View chart
Wells Fargo & Company 232k $50k -54% Dec 2023
 View chart
Renaissance Technologies 214k $28k 47% Sep 2023
 View chart
Virtu Financial 163k $35k 100% Dec 2023
 View chart
Platform Technology Partners 162k $21k 0% Sep 2023
 View chart
Wealth Enhancement Advisory Services 119k $26k 100% Dec 2023
 View chart
Bridgeway Capital Management 97k $13k -51% Sep 2023
 View chart
Modera Wealth Management 95k $20k 0% Dec 2023
 View chart
Bank of New York Mellon 90k $20k 0% Dec 2023
 View chart
Hyman Charles D 80k $17k 0% Dec 2023
 View chart
Bleakley Financial Group 60k $13k 0% Dec 2023
 View chart
Sawtooth Asset Management 60k $13k 0% Dec 2023
 View chart
Commonwealth Equity Services 50k $11k 2% Dec 2023
 View chart
Tower Research Capital 47k $6.1k 484% Sep 2023
 View chart
Jpmorgan Chase & Co 45k $9.8k 0% Dec 2023
 View chart
National Wealth Management Group 42k $9.0k -2% Dec 2023
 View chart
XTX Topco 34k $4.4k 100% Sep 2023
 View chart
Morgan Stanley 30k $0 0% Sep 2023
 View chart
Dynamic Advisors Solutions 28k $5.9k 0% Dec 2023
 View chart
Two Sigma Securities 19k $4.1k 100% Dec 2023
 View chart
Bayesian Capital Management 19k $4.1k 100% Dec 2023
 View chart
Rossmore Private Capital 18k $3.8k 0% Dec 2023
 View chart
Cooper Financial Group 14k $3.0k 0% Dec 2023
 View chart
Clarus Group 12k $2.6k 0% Dec 2023
 View chart
J.w. Cole Advisors 11k $2.3k 0% Dec 2023
 View chart
CRA Financial Services 10k $2.2k 0% Dec 2023
 View chart
Advisor Group Holdings 10k $2.2k -17% Dec 2023
 View chart
Magnus Financial Group 10k $1.3k 0% Sep 2023
 View chart
Royal Bank of Canada 7.2k $0 -4% Dec 2023
 View chart
Steward Partners Investment Advisory 3.0k $656.944000 0% Dec 2023
 View chart
EverSource Wealth Advisors 3.0k $648.900000 0% Dec 2023
 View chart
Hartford Financial Management 2.5k $541.000000 0% Dec 2023
 View chart
Advisory Services Network 2.0k $432.000000 100% Dec 2023
 View chart
Global Wealth Management Investment Advisory 650.00 $140.985000 0% Dec 2023
 View chart
IFP Advisors 643.00 $139.016600 0% Dec 2023
 View chart
Bank of America Corporation 272.00 $57.990400 100% Dec 2023
 View chart
McGlone Suttner Wealth Management 22.00 $5.000600 100% Dec 2023
 View chart

Who sold out of Matinas Biopharma Holdings, In?

Fund or Company Name Date Sold Shares Held Valued At
Jacobs Levy Equity Management Sep 2023 755k $98k
Squarepoint Ops Sep 2023 148k $19k
Jane Street Sep 2023 35k $4.5k
Baader Bank Sep 2023 34k $3.8k
SlateStone Wealth Sep 2023 10k $1.0k